Female, Han nationality, born in October 1955, from Wuji, Hebei Province, graduate degree, member of the Communist Party of China, started working in December 1973, representative of intellectuals. Currently, he is the director of the Pathogen Biology Teaching and Research Group of Anhui Medical University, party branch secretary, and subject leader.
He has successively served as a decentralized educated youth from the Zuodian Brigade of Daiji Commune, Changfeng County, Anhui Province, a lecturer, associate professor, and professor in the Pathogenic Biology Teaching and Research Office of Anhui Medical University, and the Director of the Pathogenic Biology Teaching and Research Office of Anhui Medical University. Party branch secretary. Published papers (2007-2012) Zhao Jun, Wang Mingli, Chen Jingxian. Study on cerebral cortical cell apoptosis caused by congenital latent infection with human cytomegalovirus in aged mice. Chinese Journal of Gerontology. 2007, 26(3), 209-211 . Yao Juan, Wang Mingli. Experimental study on congenital latent infection of human cytomegalovirus in the lung tissue of aged mice. Chinese Journal of Microbiology and Immunology. 2007, 27(4):349-352. Zhao Jun, Wang Mingli, Chen Jingxian . Comparison of three methods for detecting HCMV congenital infection on cerebral cortical cell apoptosis in aged mice. Journal of Anhui Medical University. 2007, 42(2), 157-160. Liu Qian, Chen Jingxian, Wang Mingli. Human Cytomegalovirus Infection Study on the correlation with the immune risk phenotype of the elderly. Life Science. 2007, 19(5), 543-546. Zhang Junling, Wang Mingli. Optimization of human cytomegalovirus plaque experimental conditions and its application in the determination of antiviral substance activity Application. Journal of Anhui Medical University. 2007, 42(5), 485-489. Huang Wei, Wang Mingli. Research on detection of IgM antibodies by indirect ELISA with recombinant HCMV pp65 combined antigen. International Journal of Biological Products. 2007, 30(6) , 248-250. Huang Wei, Wang Mingli. Establishment of the cerebral cortex model of Balb/c mice primary infected with human cytomegalovirus [J]. Journal of Anhui Medical University, 2007, 42(6): 609-611. Liu Qian , Chen Jingxian, Wang Mingli. Application of human cytomegalovirus pp65-specific antibody determination in the diagnosis of primary infection. Microorganisms and Infection. 2007, 2(3), 157-160. Xia Junbao, Duan Qiaojian, Wang Mingli. Human giant cells Research progress on the correlation between viruses and atherosclerosis. Anhui Medicine, 2009, 30(10): 1244-1246. Ni Dequn, Zhao Jiqiang, Zhang Wei, Gan Lin, Chen Jingxian, Wang Mingli. MCMV-infected mice with allogeneic skin transplantation Establishment of a qualitative pneumonia model. Journal of Anhui Medical University. 2011, 46 (6): 509-514. Ding Tingting, Chen Jingxian, Wang Mingli. Genotypic analysis of congenital infection with human cytomegalovirus in Hefei. Journal of Anhui Medical University. 2011 , 46(6):557-561 Zhang Wei, Gan Lin, Li Ruiping, Chen Jingxian, Wang Mingli. Establishment of MCMV-infected allogeneic skin transplant mouse colitis model. Acta Virology, 2011, 27(1):5-14. Achievements obtained: The research team successfully developed "Recombinant Veterinary Interferon", "Vaccine Immunization Effect Detection Series Kits" and "Infectious Birth Defect Detection TORCH Series Pathogen Diagnostic Kits", etc. Has obtained eight national invention patents. The research results of the research and development have been recommended as key industry-university-research cooperation projects by the Anhui Provincial Department of Education for many times. We participated in the International Anhui Business Conference held in Huangshan in May 2008 and the China Science and Technology Product Matchmaking Conference held in Hefei in October, as well as many projects in northern Anhui. Academic research matchmaking meeting. Two of the scientific research results were successfully signed with enterprises at the industry-university-research matchmaking conference held by the Anhui Provincial Department of Education and were jointly transformed. "HCMV Antibody Detection Kit" has obtained the test certificate from the China Institute of Food and Drug Control; "Vaccine Immunization Effect Test Series Kit" has been successfully transformed into Anhui Shubo Biotechnology Co., Ltd. and was selected into the national "Twelfth Five-Year Plan" for social development The field integration demonstration project library is applying for a new medical device certificate from the Ministry of Health; the "Recombinant Veterinary Interferon" project has been successfully transformed into Anhui Jiuchuan Biotechnology Co., Ltd., and has completed intermediate trials with the approval of the competent department of the Ministry of Agriculture and is applying for clinical trials. The test led the company to invest 110 million yuan in the first phase to build my country's first GMP factory and production line for veterinary therapeutic biological products.
Awards received: 1. From July to November 2011, the "Recombinant Veterinary Interferon" project participated in the 3rd China Innovation and Entrepreneurship Competition supervised by the Ministry of Science and Technology and co-organized by the China Science and Technology Entrepreneurship Association and the Shenzhen Municipal Government and won the top three in the country ( Second Prize). 2. From April to September 2012, the "Recombinant Veterinary Interferon" project participated in the 2012 China Science and Technology Entrepreneurship Competition co-organized by the Ministry of Science and Technology and the Ningbo Municipal Government and won the second prize.